Nalaganje...
Dengue vaccine development: status and future
Dengue, the most common arbovirus, represents an increasingly significant cause of morbidity worldwide, including in travelers. After decades of research, the first dengue vaccine was licensed in 2015: CYD-TDV, a tetravalent live attenuated vaccine with a yellow fever vaccine backbone. Recent analys...
Shranjeno v:
| izdano v: | Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer Berlin Heidelberg
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7224137/ https://ncbi.nlm.nih.gov/pubmed/31784763 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00103-019-03060-3 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|